🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy work in different ways to stop tumor ...
Status
Completed
Location
Stanford Cancer Center
Start Date
2003-02
Trial ID
NCT00084838
This phase III trial studies different chemotherapy and radiation therapy r...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2007-05-23
Trial ID
NCT00392327
This randomized phase III trial is studying gemcitabine hydrochloride, doce...
Status
Terminated
Location
Saint Joseph's Hospital and Medical Center
Start Date
2009-11
Trial ID
NCT01012297
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of ruxoliti...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2025-12-16
Trial ID
NCT07278856
Treatments Being Tested
Phase II trial to study the effectiveness of combination chemotherapy and p...
Status
Terminated
Location
Gynecologic Oncology Group
Start Date
1999-11
Trial ID
NCT00004221
This phase I trial tests the safety, side effects, and best dose of ASTX727...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2026-06-09
Trial ID
NCT07012044
This phase II trial tests the effect of dose-adjusted etoposide, prednisone...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-03-30
Trial ID
NCT07224100
This phase I trial tests the effect of allogeneic Orca-Q stem cell transpla...
Status
Not Yet Recruiting
Location
University of California Davis Comprehensive Cancer Center
Start Date
2026-09-01
Trial ID
NCT07759102
This is an open, Phase I / II clinical trial to evaluate the safety and eff...
Status
Completed
Location
Hospital Vall d'Hebron
Start Date
2016-01-07
Trial ID
NCT03157804
This randomized phase II trial compares how well adding XMO2 Filgrastim (Gr...
Status
Terminated
Location
Washington University School of Medicine
Start Date
2015-01-20
Trial ID
NCT02112045
Treatments Being Tested